Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.

Physician assistant Jill Miller shares what CLL patients really need to know about fixed-duration treatment. Learn how to manage side effects, what to expect month by month, when treatment ends, and how to navigate the emotional transition from active therapy to surveillance.

In this episode of Patient Power’s podcast Unraveling Cancer, patient host

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Michele Nadeem-Baker is joined by Deborah Stephens, DO, UNC at Chapel Hill, for a conversation about choosing a treatment for CLL, when to consider a clinical trial and the pros and cons of fixed duration vs continuous therapy.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host,

In this episode of the Patient Power podcast, Unraveling Cancer, patient host, Brad Adams is joined by Thomas Kipps, MD UC San Diego, for a conversation about why the move from chemotherapy to targeted treatments is a game changer for older CLL patients and those with co-morbidities.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host

A special from our one of our partners.

In this episode of the Patient Power podcast, Unraveling Cancer, Patient Power host, Ruth Fein and Lauren Madigan, MD, University of Utah, discuss a multi-disciplinary approach for diagnosis and treatment of systemic mastocytosis, the role of dermatology in identifying and managing skin-related symptoms, and what is in the pipeline for new therapies in the future.